hotspot -WSS

hotspot

author：explore 2025-10-01 00:07:08 - browse：529

Human embryonic stem cells Annie Cavanagh/Wellcome Images

The Food and Drug Administration on Thursday unveiled a series of guidelines that aim to encourage the development of promising and legitimate stem cell therapies while distinguishing them from the largely untested stem cell treatments hawked by unregulated clinics around the country.

The FDA’s guidelines have been expected and eagerly awaited by the stem cell community given the rapid proliferation of untested — and potentially unsafe — therapies around the country. Clinics promoting these therapies claim to be able to treat ailments from autism to neurodegenerative disorders to erectile dysfunction.

The guidelines also spell out how the agency will implement the regenerative medicine provisions in a behemoth law enacted last year called the 21st Century Cures Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： ARCH Venture Partners is raising $3 billion for a life sciences fund

hotspot

WSS

Change Healthcare outage fallout shows need for new oversight

EPA limits use of carcinogenic gas for sterilizing medical devices

Steward Health Care Massachusetts hospitals face fiscal disaster

Vertex non

Change Healthcare outage fallout shows need for new oversight

New Ultima Genomics DNA sequencer can read genome for $100

focus

hotspot

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How many hemophilia patients actually want gene therapy?

Medicare details structure of new drug price negotiation program

Male and female sex labels in research insufficient, scientists say

BioMarin wins approval for gene therapy to treat hemophilia A

First U.S. drug developed to treat liver disease MASH is approved

23andMe had bad news about my health. I wish a person had delivered it

Medicare coverage of Wegovy, once blocked, now looks possible

leisure time

HHS secretary Becerra pressed on Change HealthCare cyberattack

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Readout Newsletter: CAR

Quicker fix for pulse oximeters urged during FDA public meeting

Medicare drug price negotiation’s day in court

First U.S. drug developed to treat liver disease MASH is approved

hotspot

Wikipedia

entertainment

hotspot